Third Rock Ventures GP IV, L.P., 10% Owner at Tango Therapeutics, Inc. (TNGX), sold 285,000 shares at $9.79 ($2.8M) on 2024-08-16, disclosed to the SEC on 2024-08-20.
Open-market sale of $2.8M TNGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.79 | 135,000 | $1.3M | 46.6% |
| 2 | $10.09 | 150,000 | $1.5M | 53.4% |
| Total | $9.95 avg | 285,000 | $2.8M | 100% |
| Filing → |
| TNGX | SELL | 2024-08-01 | $3.2M | — | Filing → |
| TNGX | SELL | 2024-07-24 | $6.4M | — | Filing → |
| TNGX | SELL | 2024-07-18 | $10.8M | — | Filing → |